Search results
Roche's (RHHBY) Combo Therapy Misses Lung Cancer Study Goals
Zacks via Yahoo News· 4 days agoRoche (RHHBY) announces that its mid to late-stage lung cancer study evaluating the tiragolumab...
AI meets 'Do no harm': Healthcare grapples with tech promises
Yahoo Finance· 6 days agoCompanies have been touting the promises of artificial intelligence in healthcare, but a large...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo News· 3 days agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...